Literature DB >> 26188585

Alterations of the thrombin generation profile in rheumatoid arthritis.

Anita Kern1,2, Attila Balog3, Sonja Dulic3, Eszter Barabás4, Mária Kiszelák5, Barna Vásárhelyi4.   

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder resulting in the erosion of the cartilage and bone. Systemic involvement including the cardiovascular system with the risk of atherosclerosis may also occur. Calibrated automated thrombogram (CAT), a commercially available thrombin generation assay is suitable for the general assessment of the functionality of coagulation system. In this study we performed CAT assay in RA patients and in non-affected control subjects (matched for age, sex and comorbidities). Among the CAT parameters Velocity Index increased (from 60 to 83 nM/min), Lag Time and Time to Peak decreased (from 3.47 to 2.83 min and from 6.98 to 5.58 min respectively) in RA. On the other hand, Endogenous Thrombin Potential values decreased (from 1242 to 1108 nM min). The observed alterations were not associated with the applied therapy. These results indicate that the velocity of thrombin formation is increased, while the thrombin generating capability is reduced in RA.

Entities:  

Keywords:  Biological therapy; Rheumatoid arthritis; Thrombin generation; Thrombosis

Mesh:

Substances:

Year:  2016        PMID: 26188585     DOI: 10.1007/s11239-015-1251-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  17 in total

1.  Is there value in kinetic modeling of thrombin generation? No (unless…).

Authors:  H C Hemker; S Kerdelo; R M W Kremers
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

2.  Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.

Authors:  Hussain R Yusuf; W Craig Hooper; Scott D Grosse; Christopher S Parker; Sheree L Boulet; Thomas L Ortel
Journal:  Thromb Res       Date:  2014-10-22       Impact factor: 3.944

Review 3.  Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research.

Authors:  Armen Yuri Gasparyan; Lilit Ayvazyan; Giuseppe Cocco; George D Kitas
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 4.  Inflammation-induced thrombosis: mechanisms, disease associations and management.

Authors:  Kenan Aksu; Ayhan Donmez; Gokhan Keser
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition.

Authors:  Anetta Undas; Matthew Gissel; Beata Kwasny-Krochin; Piotr Gluszko; Kenneth G Mann; Kathleen E Brummel-Ziedins
Journal:  Thromb Haemost       Date:  2010-06-30       Impact factor: 5.249

Review 6.  Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis.

Authors:  Berthold Hoppe; Thomas Dörner
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

Review 7.  The interactions between inflammation and coagulation.

Authors:  Charles T Esmon
Journal:  Br J Haematol       Date:  2005-11       Impact factor: 6.998

Review 8.  Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Narat Srivali; Ittikorn Spanuchart; Charat Thongprayoon; Eric L Knight
Journal:  Clin Rheumatol       Date:  2014-01-15       Impact factor: 2.980

9.  C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

Authors:  Sridevi Devaraj; Dan Yan Xu; Ishwarlal Jialal
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

10.  High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism.

Authors:  A Tripodi; C Legnani; V Chantarangkul; B Cosmi; G Palareti; P M Mannucci
Journal:  J Thromb Haemost       Date:  2008-05-15       Impact factor: 5.824

View more
  4 in total

1.  Assessment of hemostatic disturbances in women with established rheumatoid arthritis.

Authors:  Aleksandra Vranic; Iva Pruner; Mirjana Veselinovic; Nida Soutari; Anica Petkovic; Vladimir Jakovljevic; Aleksandra Antovic
Journal:  Clin Rheumatol       Date:  2019-06-17       Impact factor: 2.980

2.  Simultaneous thrombosis of multiple coronary arteries in a patient with rheumatoid arthritis.

Authors:  Arzu Kalayci; Erol Arslan; Salih Murat Bakar; Mahmut Guneri; Rafet Dizman; Eylem Kivanc; Can Yucel Karabay
Journal:  J Cardiovasc Thorac Res       Date:  2016-06-28

3.  Isotypes of autoantibodies against novel differential 4-hydroxy-2-nonenal-modified peptide adducts in serum is associated with rheumatoid arthritis in Taiwanese women.

Authors:  Kai-Leun Tsai; Che-Chang Chang; Yu-Sheng Chang; Yi-Ying Lu; I-Jung Tsai; Jin-Hua Chen; Sheng-Hong Lin; Chih-Chun Tai; Yi-Fang Lin; Hui-Wen Chang; Ching-Yu Lin; Emily Chia-Yu Su
Journal:  BMC Med Inform Decis Mak       Date:  2021-02-10       Impact factor: 2.796

4.  Detection of Citrullinated Fibrin in Plasma Clots of Rheumatoid Arthritis Patients and Its Relation to Altered Structural Clot Properties, Disease-Related Inflammation and Prothrombotic Tendency.

Authors:  Johannes A Bezuidenhout; Chantelle Venter; Timothy J Roberts; Gareth Tarr; Douglas B Kell; Etheresia Pretorius
Journal:  Front Immunol       Date:  2020-12-04       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.